NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Markets Rally as US-Iran Deal Progress Lifts Sentiment

Stocks surged on Monday as optimism about an impending US-Iran deal cooled crude prices and lifted markets worldwide. A 35 paise gain in the rupee and intense buying in financial stocks also bolstered sentiment among traders. Brent crude oil fell 5% to $94.5 per barrel after US President Donald Trump indicated significant progress toward a peace deal that would reopen Iran's Strait of Hormuz, a vital artery of global energy movement.

Despite Trump later stating that the US will not rush into any deal, investors believe a resolution to the conflict is at hand. This optimism is reflected in the performance of Indian indices, with the Nifty and Sensex rising 1.32% and 1.42% respectively on Monday, closing at 24,031.70 and 76,488.96, their highest close since 15 April.

IndexMonday's ReturnPrevious High Close
Nifty1.32%24,031.70
Sensex1.42%76,488.96

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The gains were broad-based, with the Nifty midcap index closing 0.94% and the Nifty smallcap index closing 1.2% higher. All sectoral indices except the Nifty FMCG index closed in the green. The BSE's market capitalization increased by ₹5.8 trillion to ₹468 trillion.

Global indices also rose, with Japan's Nikkei 225 index closing 2.9% higher, China's CSI 300 index 1.6%, and Hong Kong's Hang Seng index 0.9%. Investors are looking through near-term volatility to assess margin resilience, pricing power, cost absorption, and the durability of growth, said Saurabh Patwa, head of equity and portfolio manager at Quest Investment Managers.

IndexMonday's Return
Nikkei 2252.9%
CSI 3001.6%
Hang Seng0.9%

With most of the March quarter earnings out, markets are becoming increasingly stock-specific, Patwa said, rewarding companies with medium-term earnings visibility despite supply-chain disruptions and inflationary pressures. Foreign portfolio investors (FPIs) net bought shares worth ₹704 crore, while domestic institutional investors (DIIs) net bought shares worth ₹3,717 crore, provisional data from the National Stock Exchange (NSE) showed.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Large-cap earnings growth slowed in the March quarter, weighed down by base effects, input costs, and global demand softness, PL Asset Management said in a report. In contrast, mid- and small-caps are accelerating strongly, driven by genuine margin expansion and operating leverage rather than just revenue tailwinds, the report added.

Earnings Growth RateFY27FY28
Nifty14.3%15.8%

Overall, Nifty earnings growth is still projected at a healthy 14.3% for FY27 and 15.8% for FY28, with relatively few companies seeing meaningful earnings downgrades, said Seshadri Sen, head of research at Emkay Global. Nearly 44% of the 500-stock universe is still expected to deliver over 25% earnings growth in FY27, Seshadri added.

However, along with expensive crude, weakness in the Indian rupee remains a concern, which may keep foreign investors cautious toward Indian equities, said Sachin Gupta, VP—Technical Research at Choice Broking. In addition, uncertainties related to monsoon conditions, food inflation, and slower corporate earnings growth could keep markets volatile, Gupta added.

In the five months of 2026, FPIs have net sold ₹2.27 trillion from Indian equity markets, higher than ₹1.6 trillion which they sold in all of 2025. Meanwhile, DIIs have net bought ₹3.8 trillion in 2026.

Investor Takeaway

Investors should remain optimistic about the global market rally driven by optimism about a US-Iran peace deal.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.